Venture Certified
| 벤처투자유형 | 2020-10-08 ~ 2022-10-07 | 20200301173 | 2020-10-08 |
| 벤처투자유형 | 2022-10-08 ~ 2025-10-07 | 20221117010007 | 2020-10-08 |
| 벤처투자유형 | 2025-10-08 ~ 2028-10-07 | 20250909010006 | 2020-10-08 |
Revenue CAGR +88.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 6.3B | 10.1B | 1.8B |
| Operating Profit | -49.0B | -41.9B | -41.3B |
| Net Profit | -49.8B | -40.2B | -43.4B |
| Total Assets | 226.5B | 68.4B | 96.7B |
| Total Liabilities | 11.6B | 5.2B | 1.8B |
| Total Equity | 214.9B | 63.2B | 94.9B |
Operating Loss: Op. profit -49B
Revenue down 38% YoY
3 Consecutive Years of Net Loss
▲ 5.6%
▼ 17.7%
▲ 43.1%
▲ 6.8%
▲ 57.6%
| Name | Position | Role |
|---|---|---|
| 김용태 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울 송파구",
"ceo_name": "김용태",
"certificate": [
{
"cert_number": "20200301173",
"changes": "",
"disclosure_date": "2020-10-08",
"first_cert_date": "2020-10-08",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2020-10-08 ~ 2022-10-07"
},
{
"cert_number": "20221117010007",
"changes": "",
"disclosure_date": "2022-11-17",
"first_cert_date": "2020-10-08",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-10-08 ~ 2025-10-07"
},
{
"cert_number": "20250909010006",
"changes": "",
"disclosure_date": "2025-09-09",
"first_cert_date": "2020-10-08",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-10-08 ~ 2028-10-07"
}
],
"company_name": "(주) 멥스젠",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 104463000,
"cost_of_sales": 54254000,
"current_assets": 8198956000,
"current_liabilities": 51234000,
"gross_profit": 123362000,
"net_income": -4342168000,
"net_income_bs": -4342168000,
"non_current_assets": 1474458000,
"non_current_liabilities": 130903000,
"non_operating_expenses": 358506000,
"non_operating_income": 144743000,
"operating_profit": -4128405000,
"revenue": 177616000,
"sga_expenses": 4251767000,
"total_assets": 9673414000,
"total_equity": 9491277000,
"total_liabilities": 182137000
},
"2023": {
"capital_stock": 104463000,
"cost_of_sales": 254382000,
"current_assets": 4385575000,
"current_liabilities": 292281000,
"gross_profit": 757453000,
"net_income": -4015669000,
"net_income_bs": -4015669000,
"non_current_assets": 2456879000,
"non_current_liabilities": 225776000,
"non_operating_expenses": 3053000,
"non_operating_income": 180081000,
"operating_profit": -4192697000,
"revenue": 1011835000,
"sga_expenses": 4950150000,
"total_assets": 6842454000,
"total_equity": 6324397000,
"total_liabilities": 518057000
},
"2024": {
"capital_stock": 140503000,
"cost_of_sales": 166140000,
"current_assets": 20016632000,
"current_liabilities": 654398000,
"gross_profit": 461929000,
"net_income": -4981190000,
"net_income_bs": -4981190000,
"non_current_assets": 2634406000,
"non_current_liabilities": 505715000,
"non_operating_expenses": 134047000,
"non_operating_income": 49794000,
"operating_profit": -4896937000,
"revenue": 628069000,
"sga_expenses": 5358866000,
"total_assets": 22651038000,
"total_equity": 21490925000,
"total_liabilities": 1160113000
}
},
"industry": "물질 검사, 측정 및 분석기구 제조업",
"investment": [
{
"amount": "4,999,803,800",
"changes": "4,999,803,800",
"date": "2024-11-13"
},
{
"amount": "4,999,000,000",
"changes": "4,999,000,000",
"date": "2022-07-08"
},
{
"amount": "2,999,973,000",
"changes": "2,999,973,000",
"date": "2020-08-28"
}
],
"main_products": "ProMEPS™(생체조직 모델링 자동화장비), MEPS-TBC WL(생체조직칩)",
"phone": "402****",
"years": [
2024,
2023,
2022
]
}